enVVeno Medical Corporation – NASDAQ:NVNO

enVVeno Medical stock price today

$4.4
+1.25
+39.68%
Financial Health
0
1
2
3
4
5
6
7
8
9

enVVeno Medical stock price monthly change

-47.41%
month

enVVeno Medical stock price quarterly change

-47.41%
quarter

enVVeno Medical stock price yearly change

-37.87%
year

enVVeno Medical key metrics

Market Cap
 46.72M
Enterprise value
 54.09M
P/E
 -2.38
EV/Sales
 N/A
EV/EBITDA
 -2.24
Price/Sales
 N/A
Price/Book
 1.47
PEG ratio
 -0.02
EPS
 -1.75
Revenue
 N/A
EBITDA
 -23.99M
Income
 -22.11M
Revenue Q/Q
 N/A
Revenue Y/Y
 N/A
Profit margin
 0%
Oper. margin
 0%
Gross margin
 0%
EBIT margin
 0%
EBITDA margin
 N/A

Get more financial ratios!

  • Every financial ratio you might need

  • 10 years history

  • Forward ratios (Analysts estimates)

Sign up &
create your own Smart Feed

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Sign up for free

enVVeno Medical stock price history

enVVeno Medical stock forecast

enVVeno Medical financial statements

Profit Margin

enVVeno Medical Corporation (NASDAQ:NVNO): Profit margin
Jun 2023 0 -6.47M
Sep 2023 0 -5.00M
Dec 2023 824K -5.64M -685.56%
Mar 2024 0 -4.99M
NVNO income statement history

enVVeno Medical Financials Estimate

enVVeno Medical Corporation (NASDAQ:NVNO): Analyst Estimates
Sep 2025 6.9M -1.73M -25.09%
Oct 2025 6.9M -2.08M -30.25%
Dec 2025 13.8M 481.71K 3.49%
Mar 2026 11.4M -133.17K -1.17%

  • Analysts Price target

  • Financials & Ratios estimates

Show more

Quarterly Earnings

enVVeno Medical Corporation (NASDAQ:NVNO): Earnings per share (EPS)
2023-03-02 -0.53069 -0.55
NVNO earnings history

Debt to Assets

enVVeno Medical Corporation (NASDAQ:NVNO): Debt to assets
Jun 2023 32086000 3.27M 10.2%
Sep 2023 28094000 3.17M 11.32%
Dec 2023 48635000 2.43M 5.01%
Mar 2024 44829000 2.46M 5.49%
NVNO balance sheet history

Cash Flow

enVVeno Medical Corporation (NASDAQ:NVNO): Cash Flow
Jun 2023 -4.56M 7.00M 0
Sep 2023 -4.21M 4.44M 0
Dec 2023 -4.97M -22.14M 25.79M
Mar 2024 -3.54M 2.19M 46K
NVNO cash flow history

enVVeno Medical alternative data

enVVeno Medical
Employees

enVVeno Medical Corporation (NASDAQ:NVNO): Employee count
Aug 2023 30
Sep 2023 30
Oct 2023 30
Nov 2023 30
Dec 2023 30
Jan 2024 30
Feb 2024 30
Mar 2024 31
Apr 2024 31
May 2024 31
Jun 2024 31
Jul 2024 31

enVVeno Medical other data

enVVeno Medical
Hedge Funds Holdings Q1 2023

1.16% -19.87%
of NVNO is owned by hedge funds
8 -14
hedge funds hold NVNO stock
100.91K -1.72M
shares is hold by hedge funds
NVNO hedge funds holdings changes

enVVeno Medical
Insider Trading

enVVeno Medical Corporation (NASDAQ:NVNO): Insider trades (number of shares)
Period Buy Sel
Mar 2024 0 8334
Dec 2024 21620 0
Transaction Date Insider Security Shares Price per share Total value Source
Purchase
BERMAN ROBERT ANDREW director, officer: Chief Execut..
 Common Stock 12,000 $2.55 $30,600
Purchase
JENUSAITIS MATTHEW director
 Common Stock 9,620 $2.53 $24,339
Option
ALAVI HAMED officer: Chief Technology Officer
 Stock Options 8,334 $3.59 $29,919
Option
ALAVI HAMED officer: Chief Technology Officer
 Common Stock 8,334 $3.59 $29,919
Sale
ALAVI HAMED officer: Chief Technology Officer
 Common Stock 8,334 $6.22 $51,837
Option
GRAY ROBERT director
 Common Stock 1,041 N/A N/A
Option
GRAY ROBERT director
 Restricted Stock Units 1,041 N/A N/A
Option
JENUSAITIS MATTHEW director
 Common Stock 1,041 N/A N/A
Option
JENUSAITIS MATTHEW director
 Restricted Stock Units 1,041 N/A N/A
Purchase
DUHAY FRANCIS director:
Common Stock 7,751 $6.14 $47,591
NVNO insider trading transactions

Frequently Asked Questions (FAQ)

  • What's the price of enVVeno Medical stock today?

    One share of enVVeno Medical stock can currently be purchased for approximately $4.4.

  • When is enVVeno Medical's next earnings date?

    Unfortunately, enVVeno Medical's (NVNO) next earnings date is currently unknown.

  • Does enVVeno Medical pay dividends?

    No, enVVeno Medical does not pay dividends.

  • How much money does enVVeno Medical make?

    enVVeno Medical has a market capitalization of 46.72M. enVVeno Medical made a loss 23.52M US dollars in net income (profit) last year or -$0.55 on an earnings per share basis.

  • What is enVVeno Medical's stock symbol?

    enVVeno Medical Corporation is traded on the NASDAQ under the ticker symbol "NVNO".

  • What is enVVeno Medical's primary industry?

    Company operates in the Healthcare sector and Medical - Devices industry.

  • How do i buy shares of enVVeno Medical?

    Shares of enVVeno Medical can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

  • How many employees does enVVeno Medical have?

    As Jul 2024, enVVeno Medical employs 31 workers.

  • When enVVeno Medical went public?

    enVVeno Medical Corporation is publicly traded company for more then 7 years since IPO on 31 May 2018.

  • What is enVVeno Medical's official website?

    The official website for enVVeno Medical is envveno.com.

  • Where are enVVeno Medical's headquarters?

    enVVeno Medical is headquartered at 70 Doppler, Irvine, CA.

  • How can i contact enVVeno Medical?

    enVVeno Medical's mailing address is 70 Doppler, Irvine, CA and company can be reached via phone at +94 92612900.

enVVeno Medical company profile:

enVVeno Medical Corporation

envveno.com
Exchange:

NASDAQ

Full time employees:

31

Industry:

Medical - Devices

Sector:

Healthcare

enVVeno Medical Corporation, a medical device company, focuses on the development of various bioprosthetic tissue-based solutions to enhance the standard of care in the treatment of venous diseases. The company's lead product is the VenoValve, a surgical implant being developed for the treatment of severe deep venous chronic venous insufficiency. Its VenoValve is implanted in the femoral vein and acts as a one-way valve to help restore proper blood flow in the leg. The company was formerly known as Hancock Jaffe Laboratories, Inc. and changed its name to enVVeno Medical Corporation in October 2021. enVVeno Medical Corporation was incorporated in 1999 and is based in Irvine, California.

+94 92612900
70 Doppler
Irvine, CA 92618

CIK: 0001661053
ISIN: US29415J1060
CUSIP: 29415J106